# Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy

> **NCT00896831** · PHASE4 · UNKNOWN · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 96 (estimated)

## Conditions studied

- Hepatic Encephalopathy

## Interventions

- **DRUG:** L-ornithine-L-aspartate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00896831
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-09
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2009-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00896831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00896831, "Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00896831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*